Back to search

Article

UGT2B7 372A>G Polymorphism Is Related To a Therapeutic Response to Lamotrigine Augmentation Therapy in Depressed Patients Who Did Not Respond to Adequate Treatment: A Preliminary Study

2022-01-17

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose:</bold> Lamotrigine is mainly metabolized by UGT1A4 and UGT2B7, both of which are expressed in the blood–brain barrier. Polymorphisms of said <italic>UGTs</italic> that affect enzyme activities have been reported. This study investigated the relationship between these polymorphisms and its therapeutic effect in 55 depressed patients who did not respond to adequate treatmen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b41a2a18-ddd1-58c3-a3d8-56e85f696493
DOI
10.21203/rs.3.rs-1262527/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
UGT2B7 372A&gt;G Polymorphism Is Related To a Therapeutic Response to Lamotrigine Augmentation Therapy in Depressed Patients Who Did Not Respond to Adequate Treatment: A Preliminary StudyDOI 10.21203/rs.3.rs-1262527/v1
Select a neighboring publication to make it the new centre.